跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 124,977 条关于
“high-grade epithelial ovarian cancer”
全部
124,977
临床试验
96,914
药物
2,661
机构
1,351
资讯
24,051
9个月前
DESTINY-Ovarian01 Phase 3 Trial Launches to Test ENHERTU as First-Line Maintenance Therapy for HER2-Expressing Ovarian Cancer
去年
Taiwan to Expand National Health Insurance Coverage for Cancer Immunotherapies and Targeted Drugs
去年
Novel CAR T-Cell Therapy Trial Advances to Third Cohort in Ovarian Cancer
去年
Breakthrough Study Reveals Hidden Cancer Cells in 42% of Ovarian Cancer Patients in Clinical Remission
2年前
Durvalumab Combo Shows Sustained PFS Benefit in Advanced Ovarian Cancer
2年前
Targeted Therapies Show Promise in High-Grade Serous Ovarian Cancer Treatment
去年
Real-World Study Confirms Bevacizumab Benefits Limited to High-Risk Epithelial Ovarian Cancer Patients
去年
PD-L1 Expression Correlates with HRD Status and Predicts Survival in High-Grade Serous Ovarian Cancer
去年
Study Finds HIPEC Does Not Improve Outcomes for Recurrent Epithelial Ovarian Cancer
去年
Novel Pan-Immune-Inflammation Nomogram Shows Promise in Predicting Epithelial Ovarian Cancer Outcomes
第 1 页，共 2406 页
上一页
下一页
